Dialysate flow was maintained at 500 mL/min and blood flow ranged from 100 to 300 mL/min according to patient characteristics
Consider a patient in her mid-40s, call her Elena, who'd been seeing a dermatologist on the Upper East Side for a couple of years

Full Ingredients: AQUA/WATER/EAU, GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, ISONONYL ISONONANOATE, PROPANEDIOL, DIMETHICONE, SQUALANE, BUTYROSPERMUM PARKII (SHEA) NUT EXTRACT, CETEARYL ALCOHOL, GLYCERYL STEARATE, PEG-100 STEARATE, PENTYLENE GLYCOL, BAKUCHIOL, ORNITHINE, TETRAHEXYLDECYL ASCORBATE, ECTOIN, NICOTIANA BENTHAMIANA HEXAPEPTIDE-40 SH-POLYPEPTIDE-47, HAEMATOCOCCUS PLUVIALIS EXTRACT, ANIGOZANTHOS FLAVIDUS EXTRACT, SILANETRIOL, HYALURONIC ACID, TOCOPHEROL, CAMELLIA SINENSIS LEAF EXTRACT, SODIUM CARRAGEENAN, PHOSPHATIDYLCHOLINE, PHOSPHOLIPIDS, GLYCOLIPIDS, PANTHENOL, HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL, PALMITIC ACID, STEARIC ACID, MANNITOL, MARIS SAL, LEVULINIC ACID, METHYLPROPANEDIOL, SODIUM HYDROXIDE, P-ANISIC ACID, PHENYLPROPANOL, POTASSIUM SORBATE, HEXYLENE GLYCOL, CAPRYLYL GLYCOL, ACRYLATES/C10-30 ALKYL ACRYLATE, VANILLA PLANIFOLIA FRUIT EXTRACT, CROSSPOLYMER, DIMETHICONE CROSSPOLYMER, PHENOXYETHANOL, ETHYLHEXYLGLYCERIN, CITRIC ACID, SODIUM BENZOATE
& Ciurtin, C
Our FOXO4-DRI 10mg is verified at 99.00% purity by reversed-phase HPLC
If Lilly submits in Q4 2026 and receives Standard Review, the FDA decision would come around August to October 2027